A groundbreaking trial for a prostate cancer treatment with fewer side effects has launched in the UK.
Backed by the Government-funded National Institute for Health and Care Research (NIHR), the trial will examine whether Aquablation – a therapy using robotics, AI and real-time imaging – works as well or better than traditional surgery, known as radical prostatectomy.